A trial investigating the effects of switching from one anitiplatelet drug to another in subject with stable Coronary Artery Disease

Registry ID

EUCTR2011-004064-29

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Daiichi Sankyo, Inc.

Start date

2012-03-20

Completion date

2013-02-13

Last update

2026-08-16

Conditions

• Stable Coronary Artery Disease

Summary

To compare the pharmacodynamic (PD) effects, expressed as P2Y12 reaction units (PRU) by the VerifyNow P2Y12 assay, in subjects with stable coronary artery disease (CAD), treated with prasugrel 10 mg daily (QD) maintenance dose (MD) (Arms A + B) and in subjects treated with ticagrelor 90 mg twice daily (BID) MD (Arm C), after 7 days of randomized study treatment.

Locations

• , , UK

Related clinical trials

• A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
• Coronary Laser Atherectomy Registry From an International Taskforce
• Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

View on source registry